Product Code: PM1099
The global point of care (PoC) diagnostics market size is expected to reach USD 115.44 billion by 2032, according to a new study by Polaris market research. The report "Point of Care (PoC) Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product; By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays); By End-Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growth of the Point-of-Care (POC) diagnostics industry attributed by, there has been a significant increase in the prevalence of infectious diseases over the past decade. This rise has created a higher demand for rapid and accurate diagnostic tests that can be performed at the point of care, enabling immediate treatment decisions and reducing the spread of these diseases.
Technological advancements have also played a crucial role in the growth of the POC diagnostics industry. With the development of innovative and user-friendly devices, patients can now receive healthcare services at home. This is particularly important for the geriatric population, who may struggle to access traditional healthcare settings. POC diagnostics enable convenient and timely healthcare delivery, improving patient outcomes and reducing the burden on healthcare systems.
The market is experiencing notable trends and developments due to the growing adoption of rapid diagnostic tests (RDTs) and their quick and on-site results, which are particularly valuable in emergency and remote healthcare settings. Technological advancements, such as miniaturization and smartphone integration, have improved the performance and accessibility of point-of-care devices. Additionally, there is an increased focus on infectious disease testing, with point-of-care tests being crucial in rapidly identifying pathogens like COVID-19, malaria, and influenza.
In addition, the shift towards personalized medicine is leveraging point-of-care diagnostics. Real-time patient data and immediate test results enable healthcare professionals to make tailored treatment decisions based on individual needs, optimizing patient care. Chronic disease management, including diabetes and cardiovascular diseases, also benefits from point-of-care diagnostics, allowing for regular biomarker monitoring and timely intervention. Moreover, the market is expanding into home healthcare, where patients can perform certain tests themselves, empowering them and facilitating remote monitoring.
Point of Care (PoC) Diagnostics Market Report Highlights
The glucose testing segment accounted for the largest share of the market due to the increasing prevalence of diabetes and related conditions.
The clinics segment dominated the market with the highest revenue shares due to the increasing development of PoC diagnostics laboratory centers within clinics.
North American region holds the largest revenue shares of the market in 2022 due to there is the presence of well-established key players in this region and their contribution to market expansion. Also, government sponsors various research bodies.
The global key market players include: Siemens Healthineers, Roche Diagnostics, Chembio Diagnostic Systems, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Instrumentation Laboratory Company, and others.
Polaris market research has segmented the Point of Care (PoC) Diagnostics market report based on product, platform, end-use, and region:
Point of Care (PoC) Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)
- Glucose Testing
- Hb1Ac Testing
- Coagulation
- Fertility
- Infectious Diseases
- HIV
- Clostridium Difficile
- HBV
- Pneumonia or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV)
- HPV
- Influenza/Flu
- HCV
- MRSA
- TB and Drug-Resistant TB
- HSV
- Others
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug Abuse Testing
- Urinalysis
Point of Care (PoC) Diagnostics, Platform Outlook (Revenue - USD Billion, 2019 - 2032)
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
Point of Care (PoC) Diagnostics, End-use Outlook (Revenue - USD Billion, 2019 - 2032)
- Clinics
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinic
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
Point of Care (PoC) Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Point of Care (PoC) Diagnostics Market Insights
- 4.1. Point of Care (PoC) Diagnostics Market - End-Use Snapshot
- 4.2. Point of Care (PoC) Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising prevalence of infectious diseases
- 4.2.1.2. Technological advancements and shift towards personalized and home healthcare
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory and quality assurance challenges
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Point of Care (PoC) Diagnostics Market End-Use Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Point of Care (PoC) Diagnostics Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 5.3. Glucose Testing
- 5.3.1. Global Point of Care (PoC) Diagnostics Market, by Glucose Testing, by Region, 2019-2032 (USD Billion)
- 5.4. Hb1Ac Testing
- 5.4.1. Global Point of Care (PoC) Diagnostics Market, by Hb1Ac Testing, by Region, 2019-2032 (USD Billion)
- 5.5. Coagulation
- 5.5.1. Global Point of Care (PoC) Diagnostics Market, by Coagulation, by Region, 2019-2032 (USD Billion)
- 5.6. Fertility
- 5.6.1. Global Point of Care (PoC) Diagnostics Market, by Fertility, by Region, 2019-2032 (USD Billion)
- 5.7. Infectious Diseases
- 5.7.1. Global Point of Care (PoC) Diagnostics Market, by Infectious Diseases, by Region, 2019-2032 (USD Billion)
- 5.7.2. HIV
- 5.7.2.1. Global Point of Care (PoC) Diagnostics Market, by HIV, by Region, 2019-2032 (USD Billion)
- 5.7.3. Pneumonia or Streptococcus Associated Infections
- 5.7.3.1. Global Point of Care (PoC) Diagnostics Market, by Clostridium Difficile, by Region, 2019-2032 (USD Billion)
- 5.7.4. HBV
- 5.7.4.1. Global Point of Care (PoC) Diagnostics Market, by HBV, by Region, 2019-2032 (USD Billion)
- 5.7.5. Pneumonia or Streptococcus Associated Infections
- 5.7.5.1. Global Point of Care (PoC) Diagnostics Market, by Pneumonia or Streptococcus Associated Infections, by Region, 2019-2032 (USD Billion)
- 5.7.6. Respiratory Syncytial Virus (RSV)
- 5.7.6.1. Global Point of Care (PoC) Diagnostics Market, by Respiratory Syncytial Virus (RSV), by Region, 2019-2032 (USD Billion)
- 5.7.7. HPV
- 5.7.7.1. Global Point of Care (PoC) Diagnostics Market, by HPV, by Region, 2019-2032 (USD Billion)
- 5.7.8. Influenza/Flu
- 5.7.8.1. Global Point of Care (PoC) Diagnostics Market, by Influenza/Flu, by Region, 2019-2032 (USD Billion)
- 5.7.9. HCV
- 5.7.9.1. Global Point of Care (PoC) Diagnostics Market, by HCV, by Region, 2019-2032 (USD Billion)
- 5.7.10. MRSA
- 5.7.10.1. Global Point of Care (PoC) Diagnostics Market, by MRSA, by Region, 2019-2032 (USD Billion)
- 5.7.11. TB and Drug-Resistant TB
- 5.7.11.1. Global Point of Care (PoC) Diagnostics Market, by TB and Drug-Resistant TB, by Region, 2019-2032 (USD Billion)
- 5.7.12. HSV
- 5.7.12.1. Global Point of Care (PoC) Diagnostics Market, by HSV, by Region, 2019-2032 (USD Billion)
- 5.7.13. Others
- 5.7.13.1. Global Point of Care (PoC) Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)
- 5.8. Cardiac Markers
- 5.8.1. Global Point of Care (PoC) Diagnostics Market, by Cardiac Markers, by Region, 2019-2032 (USD Billion)
- 5.9. Thyroid Stimulating Hormone
- 5.9.1. Global Point of Care (PoC) Diagnostics Market, by Thyroid Stimulating Hormone, by Region, 2019-2032 (USD Billion)
- 5.10. Hematology
- 5.10.1. Global Point of Care (PoC) Diagnostics Market, by Hematology, by Region, 2019 - 2032 (USD Billion)
- 5.11. Primary Care Systems
- 5.11.1. Global Point of Care (PoC) Diagnostics Market, by Primary Care Systems, by Region, 2019 - 2032 (USD Billion)
- 5.12. Decentralized Clinical Chemistry
- 5.12.1. Global Point of Care (PoC) Diagnostics Market, by Decentralized Clinical Chemistry, by Region, 2019 - 2032 (USD Billion)
- 5.13. Feces
- 5.13.1. Global Point of Care (PoC) Diagnostics Market, by Feces, by Region, 2019 - 2032 (USD Billion)
- 5.14. Lipid Testing
- 5.14.1. Global Point of Care (PoC) Diagnostics Market, by Lipid Testing, by Region, 2019 - 2032 (USD Billion)
- 5.15. Cancer Marker
- 5.15.1. Global Point of Care (PoC) Diagnostics Market, by Cancer Marker, by Region, 2019 - 2032 (USD Billion)
- 5.16. Blood Gas/Electrolytes
- 5.16.1. Global Point of Care (PoC) Diagnostics Market, by Blood Gas/Electrolytes, by Region, 2019 - 2032 (USD Billion)
- 5.17. Ambulatory Chemistry
- 5.17.1. Global Point of Care (PoC) Diagnostics Market, by Ambulatory Chemistry, by Region, 2019 - 2032 (USD Billion)
- 5.18. Drug Abuse Testing
- 5.18.1. Global Point of Care (PoC) Diagnostics Market, by Drug Abuse Testing, by Region, 2019 - 2032 (USD Billion)
- 5.19. Urinalysis
- 5.19.1. Global Point of Care (PoC) Diagnostics Market, by Urinalysis, by Region, 2019 - 2032 (USD Billion)
6. Global Point of Care (PoC) Diagnostics Market, by Platform
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 6.3. Lateral Flow Assays
- 6.3.1. Global Point of Care (PoC) Diagnostics Market, by Lateral Flow Assays, by Region, 2019-2032 (USD Billion)
- 6.4. Dipsticks
- 6.4.1. Global Point of Care (PoC) Diagnostics Market, by Dipsticks, by Region, 2019-2032 (USD Billion)
- 6.5. Microfluidics
- 6.5.1. Global Point of Care (PoC) Diagnostics Market, by Microfluidics, by Region, 2019-2032 (USD Billion)
- 6.6. Molecular Diagnostics
- 6.6.1. Global Point of Care (PoC) Diagnostics Market, by Molecular Diagnostics, by Region, 2019-2032 (USD Billion)
- 6.7. Immunoassays
- 6.7.1. Global Point of Care (PoC) Diagnostics Market, by Immunoassays, by Region, 2019-2032 (USD Billion)
7. Global Point of Care (PoC) Diagnostics Market, by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 7.3. Clinics
- 7.3.1. Global Point of Care (PoC) Diagnostics Market, by Clinics, By Region, 2019-2032 (USD Billion)
- 7.3.2. Physician Office
- 7.3.2.1. Global Point of Care (PoC) Diagnostics Market, by Physician Office, By Region, 2019-2032 (USD Billion)
- 7.3.3. Pharmacy & Retail Clinics
- 7.3.3.1. Global Point of Care (PoC) Diagnostics Market, by Pharmacy & Retail Clinics, By Region, 2019-2032 (USD Billion)
- 7.3.4. Non-practice Clinics
- 7.3.4.1. Global Point of Care (PoC) Diagnostics Market, by Non-practice Clinics, By Region, 2019-2032 (USD Billion)
- 7.3.5. Urgent Care Clinic
- 7.3.5.1. Global Point of Care (PoC) Diagnostics Market, by Urgent Care Clinic, By Region, 2019-2032 (USD Billion)
- 7.4. Hospitals
- 7.4.1. Global Point of Care (PoC) Diagnostics Market, by Hospitals, By Region, 2019-2032 (USD Billion)
- 7.5. Home
- 7.5.1. Global Point of Care (PoC) Diagnostics Market, by Home, by Region, 2019-2032 (USD Billion)
- 7.6. Assisted Living Healthcare Facilities
- 7.6.1. Global Point of Care (PoC) Diagnostics Market, by Assisted Living Healthcare Facilities, by Region, 2019-2032 (USD Billion)
- 7.7. Laboratory
- 7.7.1. Global Point of Care (PoC) Diagnostics Market, by Laboratory, by Region, 2019-2032 (USD Billion)
8. Global Point of Care (PoC) Diagnostics Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Point of Care (PoC) Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Point of Care (PoC) Diagnostics Market - North America
- 8.3.1. North America: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.3.2. North America: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.3. North America: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.3.4. Point of Care (PoC) Diagnostics Market - U.S.
- 8.3.4.1. U.S.: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.3.5. Point of Care (PoC) Diagnostics Market - Canada
- 8.3.5.1. Canada: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.4. Point of Care (PoC) Diagnostics Market - Europe
- 8.4.1. Europe: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.3. Europe: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.4.4. Point of Care (PoC) Diagnostics Market - UK
- 8.4.4.1. UK: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.4.5. Point of Care (PoC) Diagnostics Market - France
- 8.4.5.1. France: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.5.3. France: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.4.6. Point of Care (PoC) Diagnostics Market - Germany
- 8.4.6.1. Germany: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.4.7. Point of Care (PoC) Diagnostics Market - Italy
- 8.4.7.1. Italy: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.4.8. Point of Care (PoC) Diagnostics Market - Spain
- 8.4.8.1. Spain: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.4.9. Point of Care (PoC) Diagnostics Market - Netherlands
- 8.4.9.1. Netherlands: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.4.10. Point of Care (PoC) Diagnostics Market - Russia
- 8.4.10.1. Russia: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.5. Point of Care (PoC) Diagnostics Market - Asia Pacific
- 8.5.1. Asia Pacific: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.5.4. Point of Care (PoC) Diagnostics Market - China
- 8.5.4.1. China: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.4.3. China: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.5.5. Point of Care (PoC) Diagnostics Market - India
- 8.5.5.1. India: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.5.3. India: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.5.6. Point of Care (PoC) Diagnostics Market - Malaysia
- 8.5.6.1. Malaysia: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.5.7. Point of Care (PoC) Diagnostics Market - Japan
- 8.5.7.1. Japan: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.5.8. Point of Care (PoC) Diagnostics Market - Indonesia
- 8.5.8.1. Indonesia: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.5.9. Point of Care (PoC) Diagnostics Market - South Korea
- 8.5.9.1. South Korea: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.6. Point of Care (PoC) Diagnostics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.6.4. Point of Care (PoC) Diagnostics Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.6.5. Point of Care (PoC) Diagnostics Market - UAE
- 8.6.5.1. UAE: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.6.6. Point of Care (PoC) Diagnostics Market - Israel
- 8.6.6.1. Israel: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.6.7. Point of Care (PoC) Diagnostics Market - South Africa
- 8.6.7.1. South Africa: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.7. Point of Care (PoC) Diagnostics Market - Latin America
- 8.7.1. Latin America: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.7.4. Point of Care (PoC) Diagnostics Market - Mexico
- 8.7.4.1. Mexico: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.7.5. Point of Care (PoC) Diagnostics Market - Brazil
- 8.7.5.1. Brazil: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
- 8.7.6. Point of Care (PoC) Diagnostics Market - Argentina
- 8.7.6.1. Argentina: Point of Care (PoC) Diagnostics Market, by Product, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Point of Care (PoC) Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Point of Care (PoC) Diagnostics Market, by Platform, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AccuBioTech
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Becton, Dickinson and Company
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Chembio Diagnostic Systems
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Danaher Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. EKF Diagnostics
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Instrumentation Laboratory Company
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Johnson & Johnson
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Nova Biomedical
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. PTS Diagnostics
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Quidel Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Roche Diagnostics
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Sekisui Diagnostics
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Siemens Healthineers
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Trinity Biotech
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development